Tenecteplase vs. alteplase for ischemic stroke beyond 4.5 hours: a network meta-analysis of randomized controlled trials - PubMed
3 hours ago
- #meta-analysis
- #thrombolysis
- #stroke-treatment
- The article is a network meta-analysis comparing tenecteplase and alteplase for ischemic stroke beyond 4.5 hours.
- Key references include trials like HOPE (alteplase) and studies on tenecteplase in extended windows (4.5-24 hours).
- The authors declare no competing interests and note no ethical approvals or consents were applicable for this analysis.